LSE - Delayed Quote GBp

Candriam Equities L Oncology Impact (0P0001F599.L)

16,379.00 -28.00 (-0.17%)
At close: September 12 at 9:00 PM GMT+1
Loading Chart for 0P0001F599.L
DELL
  • Previous Close 16,407.00
  • YTD Return 14.60%
  • Expense Ratio 0.00%
  • Category --
  • Last Cap Gain --
  • Morningstar Rating
  • Morningstar Risk Rating Above Average
  • Sustainability Rating --
  • Net Assets --
  • Beta (5Y Monthly) 1.00
  • Yield 0.00%
  • 5y Average Return --
  • Holdings Turnover 28.67%
  • Last Dividend --
  • Inception Date Jul 29, 2019

Candriam

Fund Family

--

Fund Category

--

Net Assets

2019-07-29

Inception Date

Performance Overview: 0P0001F599.L

View More

Trailing returns as of .

YTD Return

0P0001F599.L
14.60%
Category
0.00%
 

1-Year Return

0P0001F599.L
16.67%
Category
0.00%
 

3-Year Return

0P0001F599.L
2.97%
Category
0.00%
 

5-Year Return

0P0001F599.L
0.00%
Category
0.00%
 

Holdings: 0P0001F599.L

View More

Top 10 Holdings (47.00% of Total Assets)

SymbolCompany% Assets
AZN.L
AstraZeneca PLC 5.98%
LLY
Eli Lilly and Company 5.73%
MRK
Merck & Co., Inc. 5.56%
ROG.SW
Roche Holding AG 5.02%
SHL.DE
Siemens Healthineers AG 4.72%
NOVO-B.CO
Novo Nordisk A/S 4.21%
REGN
Regeneron Pharmaceuticals, Inc. 4.18%
NOVN.SW
Novartis AG 4.06%
AMGN
Amgen Inc. 3.97%
HOLX
Hologic, Inc. 3.58%

Sector Weightings

Sector0P0001F599.L
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: 0P0001F599.L

View More

Research Reports: 0P0001F599.L

View More

Top Mutual Funds